The Operating System for the Last Mile of Science.
Life-sciences and medical-technology companies generate extraordinary volumes of evidence.
But evidence does not improve care until clinicians understand it, practices can implement it, patients can participate in decisions, and barriers to access are addressed.
Medical Impact Ventures connects independent medical education, patient and clinical intelligence, implementation science, quality improvement, longitudinal outcomes, scientific dissemination, professional reach, research infrastructure and cinematic storytelling within one closed-loop platform.
The Evidence Acceleration Company™
From Evidence to Impact™
We help science complete its journey into care
Our intelligence capabilities reveal barriers that may be preventing evidence-based care.
Our education and implementation programs address those barriers.
Our longitudinal measurement helps determine what changed.
Our scientific and media capabilities share and scale what was learned.
Every initiative strengthens our methods, expands our networks, generates scientific assets, and improves what comes next.
MIV is Not A Traditional MECC.
MIV is the Evidence Acceleration Company™.
One connected evidence-acceleration platform
Intelligence: Reveal patient, clinician, workflow, communication and access barriers that traditional data may overlook.
Education: Translate complex evidence into trusted learning for clinicians, care teams, patients and caregivers.
Implementation: Turn learning into practical tools, workflows, care pathways and measurable change.
Measurement: Track immediate and longitudinal changes in understanding, readiness, behavior, implementation and patient experience.
Dissemination: Transform findings into reports, abstracts, posters, publications, presentations and enduring scientific resources.
Scale: Apply what was learned across additional clinicians, practices, systems, communities, countries and therapeutic areas.
Technology-enabled. Human-governed.
Patient perspective: MIV brings patient and caregiver perspectives into educational and implementation strategy to identify needs, communication gaps, decision-making challenges, access barriers and experiences that may not appear in traditional datasets.
Clinical perspective: MIV evaluates factors that may influence whether clinicians, care teams and healthcare organizations are prepared to apply emerging evidence.
Connected intelligence: By bringing patient experience and clinical readiness together, MIV develops a more complete understanding of what may be preventing evidence-based care—and what can help move it forward.
Technology and AI-assisted analysis can help organize complex information, identify patterns, track longitudinal change, and surface emerging signals.
Clinical judgment, patient experience, scientific review and human accountability remain central to every initiative.
Real voices. Longitudinal learning. Actionable intelligence: AI-assisted outputs do not replace diagnosis, clinical decisions, scientific interpretation, or qualified human oversight.
The barriers between innovation and patient impact
Evidence overload: Translate rapidly changing science into clear, clinically relevant education.
Patient identification: Clarify diagnostic, testing, biomarker, referral, and treatment-evaluation pathways.
Clinical readiness: Identify gaps in knowledge, confidence, coordination, workflow, and implementation.
Patient understanding: Create accessible education that supports informed conversations and shared decision-making.
Workflow integration: Help care teams translate evidence into practical clinical processes.
Access and navigation: Address educational, communication, referral, and process barriers that may delay appropriate care.
Community implementation: Adapt academic expertise and advanced care models for community, rural, and resource-conscious settings.
Measurable change: Determine what was understood, what was implemented, what changed, and what barriers remain.
Evidence should not depend on where a patient receives care.
MIV translates evidence and academic expertise into practical education, decision support, workflows and implementation resources for diverse real-world environments.
We also bring community barriers, patient experiences and implementation learning back into the scientific conversation.
Evidence moves outward. Learning comes back.
Reach with purpose
The Right People. The Right Settings. The Right Evidence.
MIV combines access to more than two million healthcare professionals across affiliated and partner networks with patient and caregiver engagement, strategic domestic and global relationships, academic and community connections, research infrastructure and U.S. and international execution.
We help organizations engage audiences and care environments relevant to documented clinical, educational, patient, research or implementation needs—and measure what happens next.
2M+ healthcare professionals*
Patient and caregiver engagement
Academic and community connections
Domestic and global relationships
Professional reach. Patient voice. Academic expertise. Community reality. Global perspective. Longitudinal learning.
*Reach, availability, verification, consent status, permitted use and engagement methods vary by audience, geography, relationship, partner and initiative.
Independent by design
Scientific Integrity Is Built Into How We Work.
Accredited Education: Accredited education developed with qualified accredited-provider partners.
Programs are needs-driven, evidence-based, balanced and protected from commercial influence.
Independent education and implementation: Independent non-accredited education, patient education, implementation science, quality improvement, outcomes measurement, and scientific dissemination.
Programs are governed by documented educational, clinical, learner, patient, and implementation needs.
MIV’s independent educational activities are governed by documented educational and patient needs and protected from commercial influence. Other services, where applicable, are separately contracted, governed, and reviewed.
Evidence acceleration across healthcare
Life sciences: MIV helps pharmaceutical and biotechnology organizations address educational and implementation barriers surrounding scientific innovation.
Our capabilities can support evidence translation, disease-state education, diagnostics and biomarkers, patient identification, testing and referral, multidisciplinary care, workflow integration, patient education, quality improvement, longitudinal outcomes and scientific dissemination.
MIV does not direct individual treatment decisions.
Medical technology: MIV helps translate device, diagnostic, procedural and digital-health evidence into safe, effective and sustainable real-world use.
Our capabilities can support appropriate patient selection, professional education, procedural learning, site and team readiness, workflow integration, referral pathways, patient preparation, shared decision-making, monitoring education, quality improvement and outcomes measurement.